Zenith Drugs Limited
Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specializing in manufacturing and trading medicines, including generic drugs.
What Zenith files
- Others31
- Updates17
- Important12
- Board Meeting10
- Results3
- QIP/Rights/Pref.1
Zenith Drugs Limited has informed the Exchange about Copy of Newspaper Publication
Zenith Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026
Zenith Drugs' Board met, giving a green light to its 26th Annual General Meeting for Sept 29, 2026, via VC. They also appointed Agrawal & Maheshwari as Secretarial Auditors for FY26-27 and Ms. Geetika Agrawal as the AGM's E-Voting Scrutinizer.
Zenith Drugs allotted 16.09 lakh convertible warrants to promoters at Rs 43.50 each, raising 1.75 Cr initially. This move could infuse up to 7 Cr and increase promoter holding from 64.08% to 67.16% upon full conversion.
Zenith Drugs' board made key moves: re-designating Ajay Singh Dassundi to Non-Executive Director. The company also allotted 1.61 million convertible warrants to promoters at Rs 43.50 each, initially raising ₹1.75 Cr. This private placement could inject up to ₹6.99 Cr total.